Literature DB >> 19091936

Living with cystic fibrosis-related diabetes or type 1 diabetes mellitus: a comparative study exploring health-related quality of life and patients' reported experiences of hypoglycaemia.

Stephanie Tierney1, Kevin Webb, Andrew Jones, Mary Dodd, Diane McKenna, Rachel Rowe, Joanna Whitehouse, Christi Deaton.   

Abstract

OBJECTIVES: To compare patients with type 1 diabetes mellitus (T1DM) or cystic fibrosis-related diabetes (CFRD) on frequency and severity of symptoms suggestive of hypoglycaemia and diabetes-specific health-related quality of life (HRQoL).
METHODS: This was a cross-sectional comparison study. Participants with T1DM or CFRD completed a questionnaire that assessed symptoms suggestive of hypoglycaemia and diabetes-specific HRQoL, and recorded episodes of low blood sugars in a prospective diary. Comparisons of responses were conducted, and Pearson product correlations were determined between HRQoL scores and other continuous variables. HRQoL scores were compared between the groups after adjusting for confounding factors.
RESULTS: Diabetes in cystic fibrosis (CF) patients had a less negative impact on HRQoL than in T1DM patients. Both groups experienced hypoglycaemia, but loss of consciousness or needing help was more common in T1DM patients. Symptoms suggestive of hypoglycaemia were less of a problem for CFRD patients in terms of severity, with T1DM patients having more neuroglycopenic symptoms. DISCUSSION: Although the same percentage of patients in both groups reported experiencing hypoglycaemia, severity (e.g. symptoms and loss of consciousness) was higher for those with T1DM. Symptoms of hypoglycaemia appear to have a significant impact on HRQoL, and could account for the worse HRQoL in T1DM patients.

Entities:  

Mesh:

Year:  2008        PMID: 19091936     DOI: 10.1177/1742395308094240

Source DB:  PubMed          Journal:  Chronic Illn        ISSN: 1742-3953


  8 in total

Review 1.  The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism-A Review with Currently Available Evidence.

Authors:  Marina Ciochina; Daniel Vasile Balaban; George Manucu; Mariana Jinga; Cristian Gheorghe
Journal:  Biomolecules       Date:  2022-04-21

Review 2.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

3.  Content validity of the PedsQL™ 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8-45.

Authors:  James W Varni; Bradley H Curtis; Linda N Abetz; Kathryn E Lasch; Elisabeth C Piault; Andrea A Zeytoonjian
Journal:  Qual Life Res       Date:  2012-12-27       Impact factor: 4.147

4.  Cystic Fibrosis Related Diabetes: a Unique Challenge in Diabetes Care.

Authors:  Marina Litvin; Schola Nwachukwu
Journal:  Mo Med       Date:  2016 Sep-Oct

5.  Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.

Authors:  Antoinette Moran; Carol Brunzell; Richard C Cohen; Marcia Katz; Bruce C Marshall; Gary Onady; Karen A Robinson; Kathryn A Sabadosa; Arlene Stecenko; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

6.  Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis.

Authors:  Janice Abbott; Alison M Morton; Margaret A Hurley; Steven P Conway
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

Review 7.  Cystic Fibrosis-Related Diabetes.

Authors:  Kayani Kayani; Raihan Mohammed; Hasan Mohiaddin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

8.  Cystic fibrosis-related diabetes: The patient perspective.

Authors:  Kelly A Mason; Brynn E Marks; Colleen L Wood; Trang N Le
Journal:  J Clin Transl Endocrinol       Date:  2021-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.